Patents by Inventor Kumar Hari Bhushan

Kumar Hari Bhushan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for preparation of luliconazole
    Patent number: 10703744
    Abstract: A process for the preparation of luliconazole and salts thereof is disclosed.
    Type: Grant
    Filed: December 9, 2015
    Date of Patent: July 7, 2020
    Assignee: GLENMARK LIFE SCIENCES LIMITED
    Inventors: Shekhar Bhaksar Bhirud, Kumar Hari Bhushan, Sunil Sudhakar Zhope, Shailesh Govind Ghadigaonkar, Pardeep Singh, Shekhar Ashok Deshmukh, Prem Chand
  • Process for preparation of dapagliflozin
    Patent number: 10556877
    Abstract: The present invention relates to a process for the preparation of amorphous dapagliflozin. The present invention relates to 2,3-butanediol solvate of dapagliflozin and process for its preparation.
    Type: Grant
    Filed: May 4, 2016
    Date of Patent: February 11, 2020
    Assignee: Glenmark Life Sciences Limited
    Inventors: Shekhar Bhaskar Bhirud, Kumar Hari Bhushan, Raghu Ram Suraparaju, Nandkumar Gaikwad, Sharad Gore, Rajendra Jagdhane, Mandar Kulkarni
  • Process for preparation of ospemifene
    Patent number: 10138190
    Abstract: The present invention relates to a process for the preparation of ospemifene and pharmaceutically acceptable salts thereof which comprises the step of recycling the undesired E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol to generate an isomeric mixture of Z,E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol.
    Type: Grant
    Filed: January 6, 2016
    Date of Patent: November 27, 2018
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Veerabhadra Swamy, Kumar Hari Bhushan, Shekhar Bhaskar Bhirud, Dilipkumar Jibhau Patil, Eknath Kundlik Khemnar
  • Process for preparation of azelaic acid
    Patent number: 10106483
    Abstract: Provided is a process for preparing azelaic acid.
    Type: Grant
    Filed: October 21, 2015
    Date of Patent: October 23, 2018
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Shekhar Bhaskar Bhirud, Kumar Hari Bhushan, Prem Chand, Amit Anant Thanedar, Amol Anant Kadam, Krishna Baban Narawade
  • PROCESS FOR PREPARATION OF DAPAGLIFLOZIN
    Publication number: 20180127391
    Abstract: The present invention relates to a process for the preparation of amorphous dapagliflozin. The present invention relates to 2,3-butanediol solvate of dapagliflozin and process for its preparation.
    Type: Application
    Filed: May 4, 2016
    Publication date: May 10, 2018
    Inventors: Shekhar Bhaskar Bhirud, Kumar Hari BHUSHAN, Raghu Ram SURAPARAJU, Nandkumar GAIKWAD, Sharad GORE, Rajendra JAGDHANE, Mandar KULKARNI
  • PROCESS FOR PREPARATION OF OSPEMIFENE
    Publication number: 20180022674
    Abstract: The present invention relates to a process for the preparation of ospemifene and pharmaceutically acceptable salts thereof which comprises the step of recycling the undesired E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol to generate an isomeric mixture of Z,E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol.
    Type: Application
    Filed: January 6, 2016
    Publication date: January 25, 2018
    Inventors: Veerabhadra SWAMY, Kumar Hari BHUSHAN, Shekha Bhaskar BHIRUD, Dilipkumar Jibhau PATIL, Eknath Kundlik KHEMNAR
  • PROCESS FOR PREPARATION OF LULICONAZOLE
    Publication number: 20170362212
    Abstract: A process for the preparation of luliconazole and salts thereof is disclosed.
    Type: Application
    Filed: December 9, 2015
    Publication date: December 21, 2017
    Inventors: Shekhar Bhaskar BHIRUD, Kumar Hari BHUSHAN, Sunil Sudhakar ZHOPE, Shailesh Govind GHADIGAONKAR, Fardeep SINGH, Shekhar Ashok DESHMUKH, Prem CHAND
  • Process for preparation of dimethyl fumarate
    Patent number: 9840456
    Abstract: The present invention relates to a process for the preparation of dimethyl fumarate, a compound of formula I, in a purity of at least 99.0% as determined by HPLC, containing less than 400 ppm of an anion of a mineral acid and less than 5 ppm of dimethyl maleate.
    Type: Grant
    Filed: September 22, 2014
    Date of Patent: December 12, 2017
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Shekhar Bhaskar Bhirud, Kumar Hari Bhushan, H M Veerabhadra Swamy, Dilipkumar Jibhau Patil, Avikumar Digambar Dabe
  • PROCESS FOR PREPARATION OF AZELAIC ACID
    Publication number: 20170334825
    Abstract: Provided is a process for preparing azelaic acid.
    Type: Application
    Filed: October 21, 2015
    Publication date: November 23, 2017
    Inventors: Shekhar Bhaskar BHIRUD, Kumar Hari BHUSHAN, Prem CHAND, Amit Anant THANEDAR, Amol Anant KADAM, Krishna Baban NARAWADE
  • Process for the preparation of rivaroxaban
    Patent number: 9663505
    Abstract: Disclosed is a process for the preparation of rivaroxaban and purifying rivaroxaban.
    Type: Grant
    Filed: March 21, 2014
    Date of Patent: May 30, 2017
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Shrikant Prabhakar Keshav, Sanjay Shashikant Bhise, Hemant Harishchandra Kamble, Ganesh Chaudhari, Deepak Subhash Patil, Srinivas Reddy Sanikommu, Kumar Hari Bhushan, Shekhar Bhaskar Bhirud
  • PROCESS FOR PREPARATION OF DIMETHYL FUMARATE
    Publication number: 20160237021
    Abstract: The present invention relates to a process for the preparation of dimethyl fumarate, a compound of formula I, in a purity of at least 99.0% as determined by HPLC, containing less than 400 ppm of an anion of a mineral acid and less than 5 ppm of dimethyl maleate.
    Type: Application
    Filed: September 22, 2014
    Publication date: August 18, 2016
    Inventors: Shekhar Bhaskar BHIRUD, Kumar Hari BHUSHAN, H M Veerabhadra SWAMY, Dilipkumar Jibhau PATIL, Avikumar Digambar DABE
  • PROCESS FOR THE PREPARATION OF RIVAROXABAN
    Publication number: 20160052919
    Abstract: Disclosed is a process for the preparation of rivaroxaban and purifying rivaroxaban.
    Type: Application
    Filed: March 21, 2014
    Publication date: February 25, 2016
    Applicant: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Shrikant Prabhakar Keshav, Sanjay Shashikant BHISE, Hemant Harishchandra KAMBLE, Ganesh CHAUDHARI, Deepak Subhash PATIL, Srinivas Reddy SANIKOMMU, Kumar Hari BHUSHAN, Shekhar Bhaskar BHIRUD
  • Tamsulosin derivative
    Patent number: 7084301
    Abstract: The optically active compound, R (?)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-hydroxybenzenesulfonamide in good optical purity, a metabolite of the ?1-adrenergic blocking agent tamsulosin, and methods for the preparation thereof. Pharmaceutical compositions including the optically active compound and methods of treatment comprising administration of an effective ?1-adrenergic antagonistic amount of such compositions to mammals.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: August 1, 2006
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Yatendra Kumar, Ram Chander Aryan, Radhakrishnan Gowri Shankar, Kumar Hari Bhushan, Anita Chugh
  • HMG CoA-reductase inhibitors
    Patent number: 7078430
    Abstract: The invention relates to particular hydroxyl and protected hydroxyl derivatives of compounds known to be useful as HMG CoA-reductase inhibitors. In particular, herein are provided hydroxyl and protected hydroxyl compounds of Formula I and their corresponding lactones.
    Type: Grant
    Filed: May 5, 2003
    Date of Patent: July 18, 2006
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Yatendra Kumar, Ram Chander Aryan, Jitendra Sattigeri, Mohammad Salman, Gowri Shankar, Kumar Hari Bhushan, Bhargav R. Panyda, Ramnik Sharma
  • Tamsulosin derivative
    Patent number: 6894188
    Abstract: The optically active compound, R(?)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-hydroxybenzenesulfonamide in good optical purity, a metabolite of the ?1-adrenergic blocking agent tamsulosin, and methods for the preparation thereof. Pharmaceutical compositions including the optically active compound and methods of treatment comprising administration of an effective ?-adrenergic antagonistic amount of such compositions to mammals.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: May 17, 2005
    Assignee: Ranbaxy Laboratory Limited
    Inventors: Yatendra Kumar, Ram Chander Aryan, Radhakrishnan Gowri Shankar, Kumar Hari Bhushan, Anita Chugh
  • HMG CoA-reductase inhibitors
    Publication number: 20040019100
    Abstract: The invention relates to particular hydroxyl and protected hydroxyl derivatives of compounds known to be useful as HMG CoA-reductase inhibitors.
    Type: Application
    Filed: May 5, 2003
    Publication date: January 29, 2004
    Inventors: Yatendra Kumar, Ram Chander Aryan, Jitendra Sattigeri, Mohammad Salman, Gowri Shankar, Kumar Hari Bhushan, Bhargav R. Pandya, Ramnik Sharma